Company profile for TLC BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Our extensive experience with liposome science allows us to combine onset speed and benefit duration, and to improve API concentrations at target tissues while d...
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Our extensive experience with liposome science allows us to combine onset speed and benefit duration, and to improve API concentrations at target tissues while decreasing unwanted systemic exposures.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
2F, 3 Yuanqu Street, Nangang District, Taipei 11503
Telephone
Telephone
+886 2 2655 7377
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
TLC Announces TLC599 Agreement with Endo
TLC Announces TLC599 Agreement with Endo

13 Jun 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/06/13/2461013/0/en/TLC-Announces-TLC599-Agreement-with-Endo.html

GLOBENEWSWIRE
13 Jun 2022

https://www.globenewswire.com/news-release/2022/03/07/2397637/0/en/TLC-BioSciences-Announces-Publication-of-TLC599-Phase-II-Results-in-Arthritis-Research-Therapy.html

GLOBENEWSWIRE
07 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty